CONTRAFECT CORP
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch CFRXQ and buy or sell other stocks, ETFs, and their options commission-free!About CFRXQ
ContraFect Corp. is a clinical stage biotechnology company, which engages in the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections. Its product pipeline consists of CF-301, Gram-Negative Lysins, and Amurin Peptides.
CEOMichael Messinger, CPA
CEOMichael Messinger, CPA
Employees23
Employees23
HeadquartersYonkers, New York
HeadquartersYonkers, New York
Founded2008
Founded2008
Employees23
Employees23
CFRXQ Key Statistics
Market cap0.00
Market cap0.00
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume680.56
Average volume680.56
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume6.13K
Volume6.13K
52 Week high$0.0001
52 Week high$0.0001
52 Week low$0.00
52 Week low$0.00
Stock Snapshot
As of today, CONTRAFECT CORP(CFRXQ) shares are valued at $0.00. The company's market cap stands at 0.
CONTRAFECT CORP(CFRXQ) stock opened on 2026-09-08 at —. The price climbed to — and dipped to —.
CONTRAFECT CORP(CFRXQ) shares are trading with a volume of 6.13K, against a daily average of 680.56.
During the past year, CONTRAFECT CORP(CFRXQ) stock moved between $0.00 at its lowest and $0.00 at its peak.
During the past year, CONTRAFECT CORP(CFRXQ) stock moved between $0.00 at its lowest and $0.00 at its peak.
People also own
Based on the portfolios of people who own CFRXQ. This list is generated using Robinhood data, and it’s not a recommendation.